FDA Approves Genentech’s New Treatment for Wet Age-Related Macular Degeneration (AMD)

The US FDA approved Susvimo™ for intravitreal use via ocular implant for the treatment of people with wet, or neovascular, AMD who have previously responded to at least two anti-VEGF injections.